A Cell-Based Double Reporter Gene Splicing Assay for Therapeutic Screening in Myotonic Dystrophy

1 Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., H., Aburatani, Hunter, K., Stanton, V. P., Thirion, J. P., Hudson, T. & et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’ end of a transcript encoding a protein kinase family member. Cell, 68, 799-808. Search in Google Scholar

2 Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kress, W., Naylor, S. L., Day, J. W. & Ranum, L. P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864-7. Search in Google Scholar

3 Ranum, L. P. & Cooper, T. A. (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci, 29, 259-77. Search in Google Scholar

4 Charlet, B. N., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A. & Cooper, T. A.(2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to mis-regulated alternative splicing. Mol Cell, 10, 45-53. Search in Google Scholar

5 Dansithong, W., Paul, S., Comai, L. & Reddy, S.(2005) MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem, 280, 5773-80. Search in Google Scholar

6 Ho, T. H., Charlet, B. N., Poulous, M. G., Singh, G., Swanson, M. S. & Cooper, T. A.(2004) Muscleblind proteins regulate alternative splicing. EMBO J, 23, 3103-12. Search in Google Scholar

7 Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S. & Thornton, C. A.(2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet, 15, 2087-97. Search in Google Scholar

8 Miller, J. W., Urbinati, C. R., Teng-Umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A. & Swanson, M. S.(2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J, 19, 4439-48. Search in Google Scholar

9 Fardaei, M., Larkin, K., Brook, J. D., & Hamshere, M. G.(2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res, 29, 2766-71. Search in Google Scholar

10 Mankodi, A., Urbinati, C. R., Yuan, Q. P., Moxley, R. T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M. S. & Thornton, C. A.(2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet, 10, 2165-70. Search in Google Scholar

11 Kuyumcu-Martinez, N. M., Wang, G. S. & Cooper, T. A.(2007) Increased steady-state levels of CUGBP1 in myo-tonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell, 28, 68-78. Search in Google Scholar

12 Savkur, R. S., Philips, A. V. & Cooper, T. A.(2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet, 29, 40-7. Search in Google Scholar

13 Philips, A. V., Timchenko, L. T. & Cooper, T. A.(1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-41. Search in Google Scholar

14 Kalsotra, A., Xiao, X., Ward, A. J., Castle, J. C., Johnson, J. M., Burge, C. B. & Cooper, T. A.(2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc Natl Acad Sci U S A, 105, 20333-8. Search in Google Scholar

15 Gareiss, P. C., Sobczak, K., McNaughton, B. R., Palde, P. B., Thornton, C. A. & Miller, B. L.(2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J Am Chem Soc, 130, 16254-61. Search in Google Scholar

16 Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A. & Berglund, J. A.(2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci U S A, 106, 18551-6. Search in Google Scholar

17 Wheeler, T. M., Sobczak, K., Lueck, J. D., Osborne, R. J., Lin, X., Dirksen, R. T. & Thornton, C. A.(2009) Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science, 325, 336-9. Search in Google Scholar

18 Arambula, J. F., Ramisetty, S. R., Baranger, A. M. & Zimmerman, S. C.(2009) A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc Natl Acad Sci U S A, 106, 16068-73. Search in Google Scholar

19 Lee, M. M., Childs-Disney, J. L., Pushechnikov, A., French, J. M., Sobczak, K., Thornton, C. A. & Disney, M. D.(2009) Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. J Am Chem Soc, 131, 17464-72. Search in Google Scholar

20 Lee, M. M., Pushechnikov, A. & Disney, M. D.(2009) Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2. ACS Chem Biol, 4, 345-55. Search in Google Scholar

21 Pushechnikov, A., Lee, M. M., Childs-Disney, J. L., Sobczak, K., French, J. M., Thornton, C. A. & Disney, M. D.(2009) Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J Am Chem Soc, 131, 9767-79. Search in Google Scholar

22 Disney, M. D., Lee, M. M., Pushechnikov, A. & Childs-Disney, J. L. (2010) The role of flexibility in the rational design of modularly assembled ligands targeting the RNAs that cause the myotonic dystrophies. Chembiochem, 11, 375-82. Search in Google Scholar

23 O’Leary, D. A., Vargas, L., Sharif, O., Garcia, M. E., Sigal, Y. J., Chow, S. K., Schmedt, C., Caldwell, J. S., Brinker, A. & Engels, I. H. (2010) HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1. Curr Chem Genomics, 4, 9-18. Search in Google Scholar

24 Ketley, A., Chen, C. Z., Li, X., ARYA, S., Robinson, T. E., Granados-Riveron, J., Udosen, I., Morris, G. E., HOLT, I., Furling, D., Chaouch, S., Haworth, B., Southall, N., Shinn, P., Zheng, W., Austin, C. P., Hayes, C. J. & Brook, D.(2013) High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Human Molecular Genetics 1-12. Search in Google Scholar

25 Mulders, S. A., Van Den Broek, W. J., Wheeler, T. M., Croes, H. J., Van Kuik-Romeijn, P., De Kimpe, S. J., Furling, D., Platenburg, G. J., Gourdon, G., Thornton, C. A., Wieringa, B. & Wansink, D. G.(2009) Triplet-repeat oligo-nucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci U S A, 106, 13915-20. Search in Google Scholar

26 Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T. & Thornton, C. A. (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest, 117, 3952-7. Search in Google Scholar

27 Francois, V., Klein, A. F., Beley, C., Jollet, A., Lemercier, C., Garcia, L. & Furling, D. (2011) Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs. Nat Struct Mol Biol, 18, 85-7. Search in Google Scholar

28 Kanadia, R. N., Shin, J., Yuan, Y., Beattie, S. G., Wheeler, T. M., Thornton, C. A., & Swanson, M. S. (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A, 103, 11748-53. Search in Google Scholar

29 Hino, S., Kondo, S., Sekiya, H., Saito, A., Kanemoto, S., Murakami, T., Chihara, K., Aoki, Y., Nakamori, M., Takahashi, M. P. & Imaizumi, K. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum Mol Genet, 16, 2834-43. Search in Google Scholar

30 Orengo, J. P., Bundman, D. & Cooper, T. A.(2006) A bichromatic fluorescent reporter for cell-based screens of alternative splicing. Nucleic Acids Res, 34, e148. Search in Google Scholar

31 Wojciechowska, M., Sobczak, K., Kozlowski, P., Sedehizadeh, S., Wojtkowiak-Szlachcic, A., Czubak, K., Markus, R., Lusakowska, A., Kaminska, A. & Brook, J. D.(2018) Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy. Nature 8:5885, 1-13. Search in Google Scholar

32 Wang, G. S., Kuyumcu-Martinez, M. N., Sarma, S., Mathur, N., Wehrens, X. H. & Cooper, T. A.(2009) PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. J Clin Invest, 119, 3797-806. Search in Google Scholar

33 Timchenko, L.(2022) Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics. Int. J. Mol. Sci. 23(19):11954. Search in Google Scholar